Form D · Biotechnology
Medicinal Genomics Corp
Beverly, MA · CIK 0001498636
Offering snapshot reported Apr 7, 2021 · SEC filing
- Reported sold
- $2.68M Offering amount: $2.68M
- Investors reported
- 65 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 7, 2021 | Initial | $2,684,362 | No comparison | 65 | SEC filing |
| Nov 2, 2017 | Amendment | $5,003,160 | $1,208,133vs Sep 21, 2017 | 43 | SEC filing |
| Sep 21, 2017 | Initial | $3,795,027 | No comparison | 16 | SEC filing |
| Jun 15, 2015 | Initial | $7,500,000 | No comparison | 3 | SEC filing |
| Jun 19, 2014 | Initial | $6,272,598 | No comparison | 44 | SEC filing |
| Mar 26, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 7, 2011 | Initial | $8,000,000 | No comparison | 67 | SEC filing |
| Aug 16, 2010 | Initial | $7,008,402 | No comparison | 49 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-394882
Source: Form D, filed Apr 7, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John J. Altorelli | Director |
| Philip Chapman | Director |
| Patrick Costello | Executive |
| Mark H De Blois | Director |
| Charles M Farkas | Director |
| R. Brian Mc Kernan | Director, Executive |
| Brendan L Mc Kernan | Director, Executive |
| Richard Mc Kernan | Director |
| Kevin J. Mc Kernan | Executive |
| Stephen M. Mc Lean | Director |
| Emery G. Olcott | Director |
| Richard Upton | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Cummings Center Suite 406 L
Beverly, MA, 01915
Beverly, MA, 01915